医学
随机对照试验
水肿
羟乙基淀粉
临床试验
胶质瘤
伦理委员会
冲程(发动机)
脑瘤
麻醉
外科
内科学
病理
机械工程
工程类
政治学
癌症研究
公共行政
作者
Xiaoyuan Liu,Xingyue Zhang,Yifang Fan,Shu Li,Yuming Peng
出处
期刊:Trials
[Springer Nature]
日期:2022-11-19
卷期号:23 (1)
被引量:2
标识
DOI:10.1186/s13063-022-06859-9
摘要
Abstract Introduction Brain edema is the most frequent postoperative complication after brain tumor resection, especially in patients with high-grade glioma. However, the effect of SVV-based goal-directed fluid therapy (GDFT) on postoperative brain edema and the prognosis remain unclear. Methods and analysis This is a prospective, randomized, double-blinded, parallel-controlled trial aiming to observe whether stroke volume variation (SVV)-based GDFT could improve the postoperative brain edema in patients undergoing supratentorial high-grade gliomas compared with traditional fluid therapy. The patient will be given 3 ml/kg hydroxyethyl starch solution when the SVV is greater than 15% continuously for more than 5 min intraoperatively. The primary outcome will be postoperative cerebral edema volume on brain CT within 24 h. Ethics and dissemination This trial has been registered at ClinicalTrials.gov (NCT03323580) and approved by the Ethics Committee of Beijing Tiantan Hospital, Capital Medical University (reference number: KY2017-067-02). The findings will be disseminated in peer-reviewed journals and presented at national or international conferences relevant to the subject fields. Trial registration ClinicalTrials.gov NCT03323580 (First posted: October 27, 2017; Last update posted: February 11, 2022).
科研通智能强力驱动
Strongly Powered by AbleSci AI